Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

Arielle Mendel, Sasha Bernatsky, Anca Askanase, Sang-Cheol Bae, Ann Elaine Clarke, Nathalie Costedoat-Chalumeau, Dafna D Gladman, Caroline Gordon, John Hanly, Søren Jacobsen, Ken Kalunian, Anselm Mak, Marta Mosca, Bernardo A Pons-Estel, Guillermo Ruiz-Irastorza, Murray Urowitz, Évelyne Vinet

26 Citations (Scopus)
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Issue number2
Pages (from-to)1-2
Number of pages2
Publication statusPublished - Feb 2021


  • Antirheumatic Agents/supply & distribution
  • COVID-19/drug therapy
  • Health Services Accessibility
  • Humans
  • Hydroxychloroquine/supply & distribution
  • Lupus Erythematosus, Systemic/drug therapy
  • SARS-CoV-2
  • Surveys and Questionnaires
  • epidemiology
  • systemic
  • hydroxychloroquine
  • lupus erythematosus

Cite this